Study Summary
This trial will test whether fresh, donor-derived mesenchymal stem cells can safely and effectively treat new-onset type 1 diabetes. If successful, this could provide a new therapeutic option for patients with this and other autoimmune disorders.
- Type 1 Diabetes
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 4 Secondary · Reporting Duration: Over the course of 1 year (0, 1, 3, 6, 12 months)
Trial Safety
Trial Design
2 Treatment Groups
Group A Treatment
1 of 2
Group B Placebo
1 of 2
Experimental Treatment
Non-Treatment Group
60 Total Participants · 2 Treatment Groups
Primary Treatment: Mesenchymal Stem Cells (MSCs) · Has Placebo Group · Phase 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 30 · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
Tennessee | 100.0% |
What portion of applicants met pre-screening criteria?
Did not meet criteria | 100.0% |
Frequently Asked Questions
Is enrollment still available for this clinical experiment?
"According to information presented on clinicaltrials.gov, this medical trial has been open for recruitment since February 13th 2020 and was recently edited on March 23rd 2022." - Anonymous Online Contributor
To which individuals is this research endeavor open?
"To qualify for this research trial, applicants must have a diagnosis of diabetes and an autoimmune condition, as well as falling between 18-30 years old. The project is hoping to recruit around 60 participants." - Anonymous Online Contributor
What is the estimated participant count for this medical experiment?
"Affirmative. Clinicaltrials.gov verifies that this clinical trial, which has been posted since February 13th 2020 and last updated on March 23rd 2022, is currently recruiting participants for enrollment. Sixty people are being sought to take part in the study at one location." - Anonymous Online Contributor
Have the federal authorities sanctioned Mesenchymal Stem Cells (MSCs) for clinical use?
"As this is a Phase 1 study, which indicates limited evidence regarding safety and efficacy, the team at Power rated MSCs as having a score of 1." - Anonymous Online Contributor
Is there an age requirement for participants in this experiment?
"This clinical trial seeks participants aged 18-30." - Anonymous Online Contributor